Nancie Culton

Ophthalmic Complications Observed After Use of GLP-1 Agonists

January 31, 2025

You don't have permission to access "http://www.medpagetoday.com/ophthalmology/generalophthalmology/114src34" on this server. Reference #18.ade5c417.1738594511.7f2e4783 https://errors.edgesuite.net/18.ade5c417.1738594511.7f2e4783 Read More

Nancie Culton

Ophthalmic Complications Observed After Use of GLP-1 Agonists

Novo’s Weight Loss Drugs Removed from FDA Shortage List

‘Active recovery’ after exercise is supposed to improve performance—but does it really work?

The Surprising Source of Next-Gen Antibiotics: Oyster Blood

New GLP-1 Data Reinforce CV Benefit

Tool Predicts Whether One Bruise in Pediatric ED Signals Abuse

Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics

FDA Updates ‘Healthy’ Claim for Foods — but Use Is Voluntary

How Cell Therapies Help Fight Solid Tumors

AI Catches Missing MRI Lesions

FDA Approves Second Generic Daily GLP-1 Drug for T2D

Novo’s Weight Loss Drugs Removed from FDA Shortage List

‘Active recovery’ after exercise is supposed to improve performance—but does it really work?

The Surprising Source of Next-Gen Antibiotics: Oyster Blood

New GLP-1 Data Reinforce CV Benefit

Tool Predicts Whether One Bruise in Pediatric ED Signals Abuse

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories